Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-07-31
1991-08-06
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548495, C07D20912, A61K 31415
Patent
active
050378465
ABSTRACT:
This invention relates to certain polyamines found to be present in the venom of the Agelenopsis aperta spider. The polyamines of this invention and the salts thereof antagonize excitatory amino acid neurotransmitters, which neurotransmitters affect cells of various organisms, and are useful in antagonizing said neurotransmitters, per se, in the treatment of excitatory amino acid neurotransmitter mediated diseases and conditions and in the control of invertebrate pests. This invention also relates to compositions comprising said polyamines and salts thereof.
REFERENCES:
patent: 4925664 (1990-05-01), Jackson et al.
patent: 4950739 (1990-08-01), Cherksey et al.
Saccomano Nicholas A.
Volkmann Robert A.
Lumb J. Trevor
McFarlin D. Stuart
Pfizer Inc.
Richardson Peter C.
Springer David B.
LandOfFree
Indolyl-3 polyamines and their use as antagonists of excitatory does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indolyl-3 polyamines and their use as antagonists of excitatory , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indolyl-3 polyamines and their use as antagonists of excitatory will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1987367